Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails by Zhang, Y. & Reinberg, D.
REVIEW
Transcription regulation by histone
methylation: interplay between different
covalent modifications of the core
histone tails
Yi Zhang1,3 and Danny Reinberg2,4
1Department of Biochemistry and Biophysics, Curriculum in Genetics and Molecular Biology, Lineberger Comprehensive
Cancer Center, University of North Carolina at Chapel Hill, North Carolina 27599-7295, USA; 2Howard Hughes Medical
Institute, Division of Nucleic Acids Enzymology, Department of Biochemistry, University of Medicine and Dentistry of
New Jersey, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA
In this review, we discuss recent advances made on his-
tone methylation and its diverse functions in regulating
gene expression. Methylation of histone polypeptides
might be static and might mark a gene to be or not be
transcribed. However, the decision to methylate or not
methylate a specific residue in the histone polypeptides
is an active process that requires coordination among
different covalent modifications occurring at the amino
termini of the histone polypeptides, the histone tails.
Below, we summarize recent advances on histone meth-
yltransferases, and we discuss histone methylation
within the context of other histone tail modifications.
Histone modifications and the histone code hypothesis
In eukaryotic cells, genes are complexed with core his-
tones and other chromosomal proteins in the form of
chromatin. The basic repeating unit of chromatin, the
nucleosome, includes two copies of each of the four core
histones H2A, H2B, H3, and H4 wrapped by 146 bp of
DNA. With the aid of additional proteins, including his-
tone H1, the nucleosomes are further packaged into 30-
nm fibers with six nucleosomes per turn in a spiral or
solenoid arrangement (Kornberg and Lorch 1999; Hayes
and Hansen 2001). The 30-nm fiber unfolds to generate a
template for transcription, an 11-nm fiber or beads on a
string, by a mechanism that is not entirely clear. How-
ever, it is thought that unfolding involves post-transla-
tional modifications, particularly acetylation, of the core
histone amino-terminal tails.
The 11-nm fiber is also repressive to processes requir-
ing access of proteins to DNA. Recent studies have re-
vealed that there are different types of protein complexes
capable of altering the chromatin, and these may act in a
physiological context to modulate DNA accessibility.
One family includes multiprotein complexes that utilize
the energy derived from ATP hydrolysis to mobilize or
alter the structure of nucleosomes (Kingston and Narl-
ikar 1999; Vignali et al. 2000). The other family includes
protein complexes that modify the histone polypeptides
covalently, primarily within residues located at the his-
tone tails (Wu and Grunstein 2000).
As an important component of the nucleosome, each
core histone is composed of a structured, three-helix do-
main called the histone fold and two unstructured tails.
Although the histone tails are dispensable for the forma-
tion of the nucleosome, they are required for nucleo-
some–nucleosome interaction (Luger et al. 1997) and for
establishing transcriptionally repressive chromatin, re-
ferred to as heterochromatin. Transcriptionally active
chromatin within the nucleus is referred to as euchro-
matin (Grunstein et al. 1995).
The core histone tails are susceptible to a variety of
covalent modifications, including acetylation, phos-
phorylation, methylation, and ubiquitination (Fig. 1). Al-
though these modifications have been known for many
years, their functions are just beginning to be revealed.
The identification of the first nuclear histone acetyl-
transferase (HAT) as a homolog of the yeast transcrip-
tional coactivator Gcn5p (Brownell et al. 1996) fit well
with an earlier observation that acetylated histones as-
sociate with transcriptionally active genes (Hebbes et al.
1988). This important finding has led to an intensive
study of the function of histone acetylation in transcrip-
tional regulation. As a result, both biochemical and ge-
netic evidence supports an important role of histone tail
acetylation in transcriptional regulation. The important
discoveries include: (1) Several transcriptional coactiva-
tors such as Gcn5, p300/CBP, PCAF, TAF250, and the
p160 family of nuclear receptor coactivators contain in-
trinsic HAT activity (Sterner and Berger 2000; Roth et al.
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2001). (2) Global transcriptional repressors, such as Sin3
and NCoR/SMRT, among others, are associated with
histone deacetylases (HDAC; Pazin and Kadonaga 1997;
Kuzmichev and Reinberg 2001). (3) The enzymatic ac-
tivities of HAT/HDAC are required for their transcrip-
tional activation/repression activity (Hassig et al. 1998;
Kadosh and Struhl 1998; Kuo et al. 1998; Wang et al.
1998). These studies collectively demonstrate that acety-
lation of histone tails regulates gene expression by af-
fecting the dynamics of chromatin structure. In general,
acetylation of core histone tails correlates with opening
of chromatin structure to allow transcription.
In addition to acetylation, important progress has also
been made in the studies of other types of covalent modi-
fications including phosphorylation of histone H3 at
Ser10 (H3-S10) and methylation of histones H3 and H4.
The studies collectively reveal a complex interplay be-
tween the different covalent modifications occurring on
the histone tails. These studies collectively support the
histone code hypothesis (Strahl and Allis 2000). This hy-
pothesis predicts that a pre-existing modification affects
subsequent modifications on histone tails and that these
modifications serve as marks for the recruitment of dif-
ferent proteins or protein complexes to regulate diverse
chromatin functions, such as gene expression, DNA rep-
lication, and chromosome segregation. Below, we review
recent progress in histone methylation and its relation-
ship with transcriptional regulation.
Protein methylation and transcriptional regulation
Like phosphorylation, protein methylation is a covalent
modification commonly occurring on carboxyl groups of
glutamate, leucine, and isoprenylated cysteine, or on
the side-chain nitrogen atoms of lysine, arginine, and
histidine residues (Clarke 1993). Although a number
of studies have indicated a role of protein methylation
in signal transduction and RNA metabolism (Aletta et
al. 1998; Gary and Clarke 1998), the precise function
of protein methylation remains largely unknown. Be-
cause the main focus of this review is histone methyl-
ation and transcriptional regulation, and histones are
methylated on arginine and lysine residues only, the dis-
cussion will be limited to arginine and lysine methyl-
ation.
Arginine can be either mono- or dimethylated, with
the latter in symmetric or asymmetric configurations
(Fig. 2). The enzymes that catalyze this process have
been divided into two types with the type I enzyme cata-
lyzing the formation of NG-monomethylarginine and
asymmetric NG,NG-dimethylarginine residues, whereas
the type II enzyme catalyzes the formation of NG-mono-
methylarginine and symmetric NG,NG-dimethylargi-
nine residues (Fig. 2). Similar to arginine methylation,
lysine methylation on the -nitrogen can also occur as
mono-, di-, or trimethylated forms (Fig. 2). Studies in the
past several years have identified several RNA-associ-
ated proteins including hnRNP A1, fibrillarin, and
nucleolin as substrates of type I protein arginine meth-
yltransferase (PRMT), whereas the only substrate iden-
tified so far for type II PRMT is the myelin basic protein
(Gary and Clarke 1998).
First described in 1964, histones have long been
known to be substrates for methylation (Murray 1964).
Early studies using metabolic labeling followed by se-
quencing of bulk histones have shown that several lysine
residues, including lysines 4, 9, 27, and 36 of H3 and
lysine 20 of H4, are preferred sites of methylation (for
review, see van Holde, 1988; Strahl et al. 1999). In addi-
tion, members of the protein arginine methyltransferase
family can also methylate histones in vitro (Gary and
Clarke 1998). However, direct evidence linking histone
methylation to gene activity was not available until re-
cently. One major obstacle in studying the function of
histone methylation is the lack of information regarding
the responsible enzymes. Recent demonstration that a
nuclear receptor coactivator-associated protein, CARM1
(also known as PRMT4), is a H3-specific arginine meth-
yltransferase and that the human homolog of the Dro-
sophila heterochromatic protein Su(var)3–9, is a H3-spe-
cific lysine methyltransferase, provided substantial evi-
dence for the involvement of histone methylation on
transcriptional regulation (Chen et al. 1999a; Rea et al.
Figure 1. Sites of post-translational modi-
fications on the histone tails. The modifica-
tions shown include acetylation (purple),
methylation (red), phosphorylation (green),
and ubiquitination (orange). Note that Lys 9
in the H3 tail can be either acetylated or
methylated.
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2000). Below, we summarize recent progress in the stud-
ies of these two families of histone methyltransferases
(HMTs).
The PRMT family of HMTs
Protein arginine methyltransferases (PRMTs) catalyze
the transfer of methyl groups from S-adenosyl-L-methi-
onine (SAM) to the guanidino nitrogens of arginine resi-
dues (Gary and Clarke 1998). As discussed above,
PRMTs can be divided into two types on the basis of
whether they catalyze symmetric or asymmetric di-
methylation (Fig. 2). The recently identified H3-specific
arginine methyltransferase CARM1/PRMT4 (Chen et al.
1999a), belongs to the type I protein arginine N-methyl-
transferase family. This family also includes PRMT1
(Lin et al. 1996) and PRMT3 (Tang et al. 1998) from
mammals and RMT1/HMT1 from yeast (Gary et al.
1996; Henry and Silver 1996). These proteins share a con-
served catalytic core, but have little similarity outside
the core domain (Fig. 3). Sequence alignment revealed
several highly conserved regions involved in SAM bind-
ing and catalysis (Fig. 3B). Therefore, it is likely that
these enzymes use a similar reaction mechanism but
differ with regard to substrate specificity.
PRMT1 As the founding member of the PRMT family,
PRMT1 was initially identified from a yeast two-hybrid
screen as a protein interacting with the immediate-early
gene product TIS21 and the antiproliferative protein
BTG1 (Lin et al. 1996). Recombinant PRMT1 has intrin-
sic protein arginine methyl-transferase activity toward
arginine residues in RGG and RXRmotifs of many RNA-
binding proteins, including the heterogeneous nuclear
ribonucleoprotein A1 (hnRNP A1). PRMT1 was also
found to methylate histones in vitro (Lin et al. 1996).
Indeed, a recent study designed to isolate enzymes that
specifically methylate histone H4 resulted in the purifi-
cation of PRMT1 as a major H4-specific methyltransfer-
ase (Wang et al. 2001). The PRMT1 enzymatic activity
resides in a single polypeptide of ∼43 kD, which func-
tions as a 350-kD homo-oligomer (Wang et al. 2001). In
addition to interacting with BTG1 and TIS21, PRMT1
also interacts with the interferon receptor IFNAR1 and
the interleukin enhancer-binding factor 3 (ILF3;
Abramovich et al. 1997; Tang et al. 2000). All the
PRMT1-interacting proteins appear to positively modu-
late the PRMT1 enzymatic activity (Lin et al. 1996; Tang
Figure 2. Chemistry of arginine and lysine methylation. (A) Molecular structure of arginine, and mono- and di-methylarginine. Type
I and II protein arginine methyltransferases catalyze asymmetric and symmetric dimethylation, respectively. (B) Molecular structure
of lysine and mono-, di-, and tri-methyl-lysine. It is not clear whether the same HMT is able to make all the different methyl-lysines.
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et al. 2000). PRMT1 has been implicated in regulating
multiple cellular processes through methylating pro-
teins involved in nuclear–cytoplasm transport, signal
transduction, and transcription.
Figure 3. The PRMT protein family. (A) Schematic representation of five mammalian PRMT proteins. The conserved core region is
shown in red (highly conserved) and yellow (less conserved). Numbers represent amino acids. The locations of the SH3 domain in
PRMT2 and the zinc-finger domain in PRMT3 are also indicated. (B) Sequence alignment of the conserved PRMT core region. The
sequences used in the alignment include human PRMT1 (Q99873), human PRMT2 (P55345), human PRMT3 (O60678), mouse PRMT4
(AF117887), and human PRMT5 (AF015913). The alignment was performed using the MultAlin program (www.toulouse.inra.fr/
multalin.html). Amino acids with 100% and >60% conservation are shown in red and blue, respectively. The signature methyltrans-
ferase regions I, II, and III are indicated. The two loops (Double E loop and the THW loop) that form the active site (Fig. 4B) of PRMT3
are indicated. The amino acid numbers of each protein are indicated.
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Nuclear–cytoplasm transport: Although PRMT1 can
methylate several proteins in vitro (Gary and Clarke
1998), the in vivo substrates for PRMT1 are largely un-
known. However, studies on the potential yeast PRMT1
homolog ODP1/RMT1/HMT1 have indicated that
Np13p, an abundant yeast hnRNP implicated in pre-
rRNA processing and RNA transport (Russell and Tol-
lervey 1992; M.S. Lee et al. 1996), is likely to be one
of its substrates in vivo. ODP1, the gene encoding yeast
PRMT, was originally identified as an open reading
frame downstream of the gene PDX3 (Loubbardi
et al. 1995). A subsequent study demonstrated that
ODP1 encodes a predominant protein-arginine methyl-
transferase activity in yeast and was named RMT1
(Gary et al. 1996). Interestingly, this same gene was
also identified in a genetic screen aimed at isolating
proteins that interact with Np13p (Henry and Silver
1996). Because the gene product is able to methylate
the hnRNP protein Np13p in vitro and in vivo, it
was named HMT1 (Henry and Silver 1996). Although
RMT1/HMT1 is not essential for normal cell growth,
cells lacking RMT1/HMT1 and also bearing mutations
in the mRNA-binding protein Np13p are not viable.
Mutations in the SAM-binding site of PRMT1 were
shown to block methylation of Np13p in vivo, provid-
ing evidence that Np13p is an in vivo substrate (McBride
et al. 2000). Importantly, these mutations affected
the nuclear–cytoplasm transport of Np13p. In addition,
PRMT1-mediated methylation of another hnRNP,
Hrp1p, was also shown to facilitate its nuclear export
(Shen et al. 1998). Therefore, one function of argi-
nine methylation in yeast is to regulate subcellular lo-
calization of proteins. Because correct subcellular local-
ization of Np13p is necessary for pre-rRNA processing
and RNA transport (Russell and Tollervey 1992; M.S.
Lee et al. 1996), RMT1/HMT1-mediated Np13p meth-
ylation plays an important role in RNA metabolism.
Consistent with a fundamental role in RNA metabo-
lism, homozygous PRMT1mutant mouse embryos failed
to develop beyond E6.5. However, at the cellular level,
Prmt1 does not seem to be required for cell survival be-
cause PRMT1 null ES cells are viable (Pawlak et al.
2000).
PRMT1 and interferon-mediated signal transduc-
tion: In addition to regulating protein localization and
early embryonic development, several lines of evidence
suggest that PRMT1 regulates the interferon signaling
pathway. First, a yeast two-hybrid screen revealed an in-
teraction between PRMT1 and the IFNAR1 chain of the
IFN/ receptor. Importantly, disrupting PRMT1 expres-
sion through an antisense approach altered the antipro-
liferative effects of interferon (Abramovich et al. 1997).
More recent studies indicate that PRMT1 regulates the
transcriptional activity of STAT1 (signal transducers and
activators of transcription) by methylating the protein
on Arg 31, a residue conserved in all seven mammalian
STATs (Mowen et al. 2001). STAT1 is a latent cytoplas-
mic transcription factor that is activated by a large num-
ber of extracellular signals including growth factors and
cytokines (Schindler and Darnell 1995). Methylation of
STAT1 by PRMT1 enhances its DNA-binding activity.
Importantly, inhibition of the PRMT1methyltransferase
activity by the methylation inhibitor 5-methyl-thioad-
enosine (MTA), crippled STAT1-mediated transcrip-
tional activation and interferon responsiveness (Mowen
et al. 2001). Because MTA accumulation in transformed
cells correlates with the lack of interferon responsive-
ness, methylation of STAT1 is likely to play an impor-
tant role in the regulation of cellular proliferation (Mo-
wen et al. 2001). Therefore, these studies collectively
suggest that PRMT1-mediated STAT1methylation regu-
lates both STAT1 transcriptional activity and cellular
proliferation.
Histone methylation and transcription activation: In
addition to methylating transcription factors such as
STAT1, PRMT1 also participates in transcriptional regu-
lation through methylation of core histones. Although
PRMT1methylates histones in vitro (Lin et al. 1996), the
ability of histones to serve as substrates for PRMT1 in
vivo was questioned for two reasons. First, histones are
much less efficient substrates of PRMT1when compared
with hnRNP A1 (Gary and Clarke 1998). Second, in vivo
labeling experiments have shown that bulk histones are
methylated on lysines only (Strahl et al. 1999). However,
recent studies using mass spectrometry and a highly spe-
cific antibody recognizing histone H4 methylated at Arg
3 have unequivocally demonstrated that histone H4 is a
substrate for PRMT1 in vivo (Wang et al. 2001; Strahl et
al. 2001).
In an effort to isolate enzymes that methylate core
histones, Wang and colleagues purified one of the most
abundant H4-specific HMTs from HeLa cells. The enzy-
matic activity correlated with a single polypeptide iden-
tified as PRMT1 and the methylation site was identified
to be Arg 3 (Wang et al. 2001). Importantly, an antibody
that specifically recognized methylated H4-R3 recog-
nized histone H4 purified from HeLa cells (Wang et al.
2001; Strahl et al. 2001). Methylation on H4-R3 is not
limited to mammalian cells, as the highly specific anti-
body also recognized H4 purified from chicken and yeast
(Strahl et al. 2001). PRMT1 is likely to be the most
prominent methyltransferase responsible for methyl-
ation of H4-R3, as methylation on this residue was not
detected when histone H4 was isolated from PRMT1-
null ES cells (Wang et al. 2001). Consistent with poten-
tial roles of PRMT1 in transcription, PRMT1-mediated
methylation of H4-R3 facilitates subsequent acetylation
of histone H4 by p300 (Wang et al. 2001). This observa-
tion provides a molecular explanation to the recent dem-
onstration that PRMT1 function as a transcriptional co-
activator of nuclear hormone receptors when coex-
pressed with members of the p160 family of coactivators
(Koh et al. 2001). Significantly, the enzymatic activity of
PRMT1 is required for its coactivator function, because a
mutation of the SAM-binding site of PRMT1 crippled
PRMT1 enzymatic activity as well as PRMT1 coactiva-
tor function (Wang et al. 2001). Thus, the above studies
demonstrate that PRMT1 plays an important role in
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methylation of H4-R3 and its histone methyltransferase
activity is involved in transcriptional activation.
CARM1/PRMT4 The coactivator-associated arginine
methyltransferase 1 (CARM1) was identified in a yeast
two-hybrid screen using as bait the carboxy-terminal do-
main of GRIP1, a member of the p160 family of coacti-
vators (Chen et al. 1999a). Extensive sequence homology
between the central portion of CARM1 and members of
the PRMT family prompted the testing of CARM1 for
methyltransferase activity. CARM1 preferentially meth-
ylates histone H3 in vitro (Chen et al. 1999a), and map-
ping of the residues demonstrated specificity for Arg 2,
Arg 17, and Arg 26 (Schurter et al. 2001). CARM1 also
methylates the carboxyl terminus of histone H3 at one
or more of the four arginine (128/129/131/134) residues
(Schurter et al. 2001). However, which residue(s) is/are
methylated by CARM1 in vivo remains to be deter-
mined.
CARM1 is a coactivator that participates in transcrip-
tional regulation in the presence of the p160 family of
coactivators. Importantly, a mutation in the putative
SAM-binding domain of CARM1 substantially reduced
both its methyltransferase and coactivator activities
(Chen et al. 1999a). This finding strongly suggests that
arginine methylation is the molecular mechanism
of transcriptional coactivation by CARM1. However,
whether histones or other polypeptides are the substrate
of CARM1 remains an open question. Recent studies
demonstrated that the histone acetyltransferase p300
and CARM1 synergistically enhance transcription from
the estrogen receptor (Koh et al. 2001). Consistent with
the findings that CARM1 functions together with the
p160 family of coactivators, the synergy between
CARM1 and p300 requires GRIP1 (Chen et al. 2000). Of
relevance in understanding the function of CARM1 in
transcription is to know whether the synergistic affect
between p300 and CARM depends on their enzymatic
activity. Elucidating these functional interactions is
likely to reveal new insights into the interplay between
histone acetylation and histone methylation (see below)
and is likely to shed light on coactivator activities di-
rectly regulated by acetylation and/or methylation.
Other members of the PRMT family In addition to
PRMT1 and CARM1/PRMT4, three other mammalian
proteins belonging to the PRMT family have been re-
ported. The gene encoding PRMT2 was identified by
screening the EST (expressed sequence tag) databases
(Katsanis et al. 1997). Whether PRMT2 possesses protein
arginine methyltransferase activity remains to be dem-
onstrated.
PRMT3 was identified in a yeast two-hybrid screen
using PRMT1 as bait (Tang et al. 1998). PRMT3 func-
tions as a monomer and is predominantly localized in
the cytoplasm (Tang et al. 1998). Recombinant PRMT1
and PRMT3 seem to have distinctive substrate specific-
ity. In hypomethylated rmt1-derived extracts, GST–
PRMT1 and GST–PRMT3 methylate a 45-kD protein
and a 28-kD protein, respectively. Both proteins, how-
ever, methylate a 14-kD species (Tang et al. 1998). A
unique feature of PRMT3 is the presence of a zinc finger
at its amino terminus (Fig. 3A). This zinc finger is re-
quired for recognition of RNA-associated substrates in
RAT1 cell extracts and, therefore, appears to play an im-
portant role in determining substrate specificity of
PRMT3 (Frankel and Clarke 2000).
PRMT5 is the newest member of the PRMT protein
family. It was first identified as a human homolog of the
Schizosaccharomyces pombe Shk1 kinase-binding pro-
tein 1, SKB1Hs (Gilbreth et al. 1998) and was later iden-
tified as a Jak (Janus kinase)-binding protein (JBP1) in a
yeast two-hybrid screen using Jak2 as bait (Pollack et al.
1999). Amino acid sequence similarity between SKB1/
JBP1 and the Saccharomyces cerevisiae homolog HSL7
(histone synthetic lethal 7) and other members of the
PRMT protein family suggested that this protein might
be a protein arginine methyltransferase. This activity
was demonstrated with recombinant JBP1 and Hsl7p
(Pollack et al. 1999; Lee et al. 2000; Rho et al. 2001), and
the protein was renamed PRMT5. PRMT5 is localized
predominantly in the cytoplasm (Rho et al. 2001) and is
able to methylate myelin basic protein, fibrillamin, and
histones H2A and H4 in vitro (Pollack et al. 1999; Lee et
al. 2000; Rho et al. 2001). Whether any of these proteins
are substrates of PRMT5 in vivo remains to be deter-
mined. Although most PRMTs belong to the type I pro-
tein arginine methyltransferase family , recent studies
have revealed that PRMT5 can catalyze the formation of
symmetric dimethylarginine and, therefore, belongs to
type II enzyme family (Branscombe et al. 2001). The ex-
act function of PRMT5 remains to be elucidated, but
studies described below suggest that PRMT5 might be
involved in mitosis.
Skb1 was found to be a negative regulator of mitosis as
the protein associates with the cdc2 complex in S.
pombe, and skb1-null mutants exhibited phenotypes
characteristic of mitotic inhibitors (Gilbreth et al. 1998).
Moreover, HSL7 was found to be a negative regulator of
the Swe1 kinase, an important cell cycle regulator (Ma et
al. 1996). Therefore, PRMT5 likely plays an important
role in cell cycle regulation. Whether this function is
mediated through histone polypeptides remains to be de-
fined. It is potentially important, however, that HSL7
was initially identified in a genetic screen scoring for
genes whose mutation is lethal in combination with a
deletion of the histone H3 tail (Ma et al. 1996).
The above results suggest a role for PRMT5 in mitosis
as well as in regulating the interferon signal transduction
pathway. This later finding with PRMT5 revealed a func-
tion similar to the function of PRMT1 in regulating
STAT1 (Mowen et al. 2001). Whether STAT1 can also be
methylated by PRMT5 remains to be determined.
Structure of the PRMT proteins Great progress has
been made recently in determining the crystal structures
of two members of the PRMT family, the rat PRMT3
(Zhang et al. 2000) and the yeast Rmt1/Hmt1 (Weiss et
al. 2000). The PRMT proteins vary in size but they all
Zhang and Reinberg
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contain conserved catalytic core regions (Fig. 3). Crystal-
lographic studies of the core region of the rat PRMT3
have revealed the following features: (1) The overall
structure of the PRMT3 core can be divided into two
domains—an AdoMet-binding domain and a barrel-like
domain (Fig. 4A). The AdoMet-binding domain is a typi-
cal Rossmann fold (green) plus two amino-terminal he-
lices (red) with a bound AdoHcy (S-adenosyl-homocyste-
ine) (light blue). (2) The active site is situated in a deep
pocket between the two domains. The residues that
make up the active site are conserved across the PRMT
family, consisting of a 12-residue double-E loop contain-
ing two invariant Glu (E326 and E355 in rat PRMT3) and
one His–Asp proton-relay system (Fig. 4B). It is believed
that the pocket would accommodate the side chain of an
arginine so that the terminal amino group could reach
the AdoMet (Zhang et al. 2000). The residues lining the
pocket include the negatively charged Glu 326 and Glu
355, and the hydrophobic amino acids Phe 334 and Tyr
330. This arrangement fits well with the asymmetric
polarity of the substrate arginine residues. In the absence
of the target arginine, the active site is occupied by five
ordered water molecules, three of which (sites 1, 2, and 3)
directly interact with Glu 326, Glu 335, and His 476 (Fig.
4B). (3) PRMT3 forms a dimer mediated by a three-helix
insertion into the barrel domain.
Crystallographic studies of the yeast arginine methyl-
transferase Rmt1/Hmt1 revealed that Hmt1 forms a
hexamer composed of three dimers (Weiss et al. 2000).
The surface of the oligomer is dominated by large acidic
cavities at the dimer interfaces. The ability of Hmt1 to
oligomerize is critical for its enzymatic activity as mu-
tations disrupting the dimer contact sites eliminated its
enzymatic activity both in vitro and in vivo (Weiss et al.
2000). Similar to PRMT3, the Hmt1 monomer also con-
sists of two domains (Weiss et al. 2000). These structure
features suggest that all the PRMT family members are
likely to have a similar core domain structure and, there-
fore, use a similar mechanism for catalysis. The differ-
ences are likely to reside in the nonconserved regions,
that is, the amino- and/or carboxy-terminal regions,
which likely determine the substrate specificity and the
ability to form oligomers.
SET domain family of HMTs
The SET domain is an evolutionarily conserved se-
quence motif initially identified in the Drosophila posi-
tion effect variegation (PEV) suppressor SU(VAR)3–9
(Tschiersch et al. 1994), the Polycomb-group protein En-
hancer of zeste (Jones and Gelbart 1993), and the tritho-
rax-group protein Trithorax (Stassen et al. 1995). Over
200 proteins of diverse functions, ranging from mam-
mals to bacteria and viruses, have been identified to con-
tain this motif (http://sMART.embl-heidelberg.de/smart/
do_annotation.pl?DOMAIN=SET&BLAST=DUMMY). A
major function of the SET domain-containing proteins is to
modulate gene activity (Jenuwein et al. 1998). However,
the underlying mechanism is not understood. A clue that
the SET domain may be an important signature motif for
protein methyltransferases came from studies on several
plant SET-domain-containing proteins, where it was found
that several of the proteins possessed protein methyltrans-
ferase activity (Klein and Houtz 1995; Zheng et al. 1998).
We discuss SET domain proteins and histone methylation
below.
SUV39H1 and SUV39H2 As one of the founding mem-
bers of the SET domain protein family, Drosophila Su-
(var) 3–9 was identified in genetic screens aimed at iso-
lating suppressors of PEV (Tschiersch et al. 1994). In ad-
Figure 4. Structure of the rat PRMT3 catalytic core in complex with reaction product AdoHcy. (A) Overall structure of the PRMT3
core domain. The two amino-terminal helices (red), the AdoMet-binding domain (green), the barrel-like structure (yellow), and the
three-helix arm (yellow) are indicated. The active site, composed of the double E loop and the THW loop, are also indicated. (B) A close
view of the active site pocket. The amino acid number corresponds to the rat PRMT3. The five water molecules (1–5) in the active site
are indicated. Courtesy of Dr. Xiaodong Cheng.
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dition to the SET domain, the Su(var) 3–9 protein also
contains an evolutionarily conserved chromodomain
found in a group of chromatin-related proteins (Koonin
et al. 1995). Mutations in the fission yeast homolog clr4
disrupt the association of Swi6p with heterochromatin
and result in chromosome segregation defects (Ekwall et
al. 1996). Studies with the human (SUV39H1), and
mouse (Suv39h1) homologs of Su(var)3–9 demonstrated
that the encoded polypeptide associates with the mam-
malian heterochromatic protein HP1, a homolog of
Swi6p (Aagaard et al. 1999). Therefore, the function of
SUV39H1/Clr4 and HP1/Swi6p in heterochromatic gene
silencing seems to be conserved from yeast to human.
Core histones have long been known to play important
roles in heterochromatic gene silencing (Grunstein
1998), but the role of histone methylation in heterochro-
matin silencing was not known until recently. The dem-
onstration that Suv39H1 and Clr4 possess intrinsic his-
tone methyltransferase activity supports a role of his-
tone methylation in heterochromatin silencing (Rea et
al. 2000).
The sequence similarity between the SET domain of
SUV39H1 and some plant SET-domain-containing meth-
yltransferases (Klein and Houtz 1995; Zheng et al. 1998)
prompted Jenuwein and colleagues to test for possible
methyltransferase activity associated with SUV39H1.
This study revealed that SUV39H1 and its S. pombe ho-
molog Clr4 contain intrinsic histone methyltransferase
activity. The enzyme specifically methylates histone H3
on lysine 9 (H3-K9; Rea et al. 2000). Mutagenesis studies
with Suv39H1 showed that the SET domain and two
adjacent cysteine-rich regions (preSET and postSET) are
required for enzymatic activity (Fig. 5). Consistent with
the requirement of these three regions for enzymatic ac-
tivity, other SET domain-containing proteins that lack
one or more of the cysteine-rich regions, for example,
recombinant EZH2 and TRX, do not contain histone
methyltransferase activity in vitro (Rea et al. 2000). It is
important to point out, however, that it is not known
whether the native EZH2 and TRX protein complexes
have HMT activity. Moreover, there are other SET do-
main-containing proteins that are devoid of one or both
of the cysteine-rich domains, yet contain histone meth-
yltransferase activity (Fig. 5 and see below).
Although Suv39h-null primary mouse embryonic fi-
broblasts (PMEFs) exhibited mitotic defects, the methyl-
ation level of H3-K9 of bulk histones appears unchanged
when compared with those derived from wild-type cells
(Rea et al. 2000); therefore, additional H3-K9-specific
methyltransferases exist in the cell. Consistent with this
idea, a second murine K9-specific HMT was recently
identified (O’Carroll et al. 2000). This murine gene,
termed Suv39h2, encodes a protein that is 59% identical
to the murine Suv39h1. The major difference between
these two proteins is the presence of a highly basic
amino terminus in Suv39h2. Although Suv39h1 and
Suv39h2 display overlapping expression profiles during
mouse embryogenesis, Suv39h2 transcripts are uniquely
expressed in the testis of adult mice. Because Suv39h2
specifically accumulates on the sex chromosomes (XY
body), which undergo transcriptional silencing during
the first meiotic prophase, the HMT activity of Suv39h2
was proposed to be involved in organizing meiotic het-
erochromatin and genomic imprinting of the male germ
line (O’Carroll et al. 2000). The proposed functions for
Suv39h2 remains to be demonstrated.
Figure 5. Sequence alignment of the SET and postSET domains of known HMTs. The sequences used in the alignment include
human SUV39h1 (NP_003164), S. pombe Clr4 (T43945), human G9a (NP_006700), S. cerevisiae SET1 (P38827) and SET2 (P46995), and
their potential human homologs (AB002337 and AJ238403). The alignment was performed with the MultAlin program (www.toulou-
se.inra.fr/multalin.html). Amino acids with 100% and >50% conservation are shown in red and blue, respectively. SET and postSET
domains are indicated. The amino acids known to affect HMT activity are indicated by red dots on top of the sequence. The amino
acid numbers of each protein are also indicated.
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G9a and other SET domain-containing proteins In ad-
dition to the SUV39H1 and SUV39H2 HMTs, another
SET domain-containing protein G9a has recently been
shown to be an HMT (Tachibana et al. 2001). The gene
encoding G9a is located in the class III region of the
human major histocompatibility complex locus (Milner
and Campbell 1993). Like the Suv39h family of proteins,
G9a contains the SET domain as well as the adjacent
cysteine-rich preSET and postSET domains (Rea et al.
2000). In addition, G9a also contains a polyglutamic acid
stretch and six continuous ankyrin repeats at its amino
terminus. The existence of a SET domain and adjacent
cysteine-rich regions prompted Tachibana and col-
leagues to test the ability of G9a protein to methylate
core histones. Like the Suv39h family of HMTs, G9a is
able to specifically methylate histone H3 at lysine 9, but
also at lysine 27, a site reported to be methylated in vivo
(Strahl et al. 1999). Interestingly the two H3-K residues
targeted by G9a in vitro are contained within strikingly
similar amino acid sequences, suggesting that G9amight
recognize the lysine residue within a motif (TKXX-
ARKS). The specific activity of G9a is 10- to 20-fold
higher than that of Suv39h1 (Tachibana et al. 2001).
Fluorescent labeling studies indicated that G9a and
Suv39h1 have distinctive localization patterns suggest-
ing that these enzymes perform distinct functions.
A database search revealed that, in addition to G9a and
the Suv39h1 family of proteins, other proteins with
SET, preSET, and postSET domains exist. For example,
CLLD8, a candidate gene for leukemogenesis at chromo-
some 13q14, contains a split SET domain and the adja-
cent preSET and postSET cysteine-rich regions (Mabuchi
et al. 2001). Interestingly, this protein also contains a
region with similarity to the methyl-CpG-binding do-
main (MBD) of the MeCP2 protein (Hendrich and Bird
1998). Similar bifurcated SET, preSET, postSET, and
MBD domains were also found in the SETDB1 protein
(Harte et al. 1999) and its mouse homolog ESET, which
interacts with ERG, a member of the ETS-family of tran-
scription factors (Liu Yang, pers. comm.). Preliminary
studies indicate that ESET possesses H3-specific HMT
activity, raising the possibility that the transcription fac-
tor ERG may participate in transcriptional regulation
through ESET-mediated histone methylation (Y.Z, un-
publ.). The finding that a split SET domain-containing
protein possesses HMT activity suggests that the SET
domain can be separated into two subdomains without
destroying its enzymatic activity.
Is the SET domain sufficient for enzymatic activity?
The SET domain-containing HMTs described above all
contain the preSET and postSET domains believed to be
required for their enzymatic activity (Rea et al. 2000).
Analysis of the S. cerevisiae genome database identified
six SET domain-containing proteins, yet none of these
proteins contains both the preSET and postSET domains.
Indeed, only Set1 and Set2 proteins contain the postSET
domain (Fig. 5), the other proteins only contain the SET
domain. The histones in yeast are clearly methylated
(Strahl et al. 1999), and the specificity of Set1 [H3-K4 (D.
Allis and T. Kouzarides, pers. comm.)] and Set2 [core
domain of histone H3 (T. Kouzarides, pers. comm.)] pro-
teins do not account for all the histone methylation ob-
served in yeast. Therefore, the preSET and/or postSET
domains appear not to be essential for enzymatic activ-
ity. Moreover, a new HMT with specificity to H3-K4,
which contain neither preSET nor postSET domains was
isolated from HeLa cells (Y. Zhang unpubl.). Moreover,
an HMT isolated from HeLa cells with specificity for
nucleosomal H4-K20 is also devoid of the preSET and the
postSET domains (D. Reinberg, unpubl.). Therefore, it is
likely that the SET domain is the only signature motif
for HMTs. The function of the adjacent cysteine-rich
preSET and postSET domains might be replaced by other
motifs or might be dispensable if the SET-domain con-
taining HMT exists in a protein complex. For example,
the SET domain of Clr4 is sufficient for HMT activity in
vitro; however, the chromodomain and the SET domains
are both required for activity in vivo (Nakayama et al.
2001). The precise domain requirement for HMT activity
and the role of preSET and postSET in histone methyl-
ation await further studies.
Coupling histone methylation with DNA methyla-
tion The fact that HMTs like CLLD8 and SETDB1/
ESET contain a potential methyl-CpG-binding domain
(MBD) raises the important possibility that histone
methylation, similar to histone deacetylation (Bird and
Wolffe 1999), might function in concert with DNA
methylation. As outlined in Figure 6, different modes
might be used to couple DNA and histone methylation
processes. Methyl-CpG-binding proteins may recruit
histone deacetylase complexes to deacetylate histone
tails so that the tails become suitable for serving as sub-
strates for methylation (Fig. 6A). In contrast with this
sequential process, MBD-containing HMTs may bind di-
rectly to methylated nucleosomal DNA to methylate
histone tails (Fig. 6B). Alternatively, it is also possible
that chromodomain-containing proteins bind to methyl-
ated histone tails and recruit DNA methyltransferase
(DNMT) to methylate adjacent CpG sequences (Fig. 6C).
Irrespective of the sequence of events, it is likely that a
concerted action of HMT and HDAC complexes may
play an important role in methylated DNA silencing
(Fig. 6).
Chromodomain, H3-K9 methylation, and heterochro-
matin formation Post-translational modifications have
long been known to affect protein–protein interactions.
For example, phosphorylation on the tumor suppressor
protein Rb affects its interaction with the transcription
factor E2F (Harbour and Dean 2000). Recent studies have
revealed that acetylation on a protein also affects its as-
sociation with other proteins. For example, the nuclear
hormone receptor coactivator ACTR can be acetylated
by p300/CBP and this modification disrupts the associa-
tion of the ACTR complex with promoter-bound estro-
gen receptors (Chen et al. 1999b). In a similar manner,
histone modifications have been proposed to serve as
markers, termed the histone code, that are recognized by
Transcription regulation by histone methylation
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other proteins (Strahl and Allis 2000; Turner 2000). One
piece of evidence that supports this hypothesis is the
demonstration that the bromodomain and double bro-
modomain of the histone acetyltransferases PCAF and
TAF250, respectively, bind preferentially to specific
acetylated lysines on histone tails (Dhalluin et al. 1999;
Jacobson et al. 2000). The ability to recognize modified
histone tails does not seem to be limited to the bromo-
domain. Recent demonstration that the chromodomain
present in the heterochromatin protein HP1 binds spe-
cifically to methylated H3-K9 further supports the his-
tone code hypothesis (Bannister et al. 2001; Lachner et
al. 2001; Nakayama et al. 2001).
Previous studies have indicated that the heterochro-
matin-associated protein HP1 and its S. pombe homolog
Swi6p are required for heterochromatin formation. Im-
portantly, HP1 colocalizes with SUV39H1 (Aagaard et al.
1999). In addition, heterochromatin localization of
Swi6p requires functional Clr4 (Ekwall et al. 1996). The
chromodomains in the HP1/Swi6p proteins have been
implicated in their heterochromatic localization (Platero
et al. 1995). These observations collectively suggest that
the chromodomain of HP1/Swi6p recognizes the H3-K9
methylated by SUV39H1/Clr4. Three groups have re-
cently provided supporting evidence for this possibility
(Bannister et al. 2001; Lachner et al. 2001; Nakayama et
al. 2001). The binding is highly specific because a K9-
methylated H3 peptide, but not a K4-methylated peptide
displaced HP1 and, importantly, other chromodomain-
containing proteins, including SUV39H1 and Mi-2,
failed to bind to methylated H3-K9 peptide. Interest-
ingly, one HP1 chromodomain mutant (V23M) that dis-
rupts the methylated K9-specific binding activity also
disrupts the gene silencing function of Drosophila HP1
(Platero et al. 1995). These findings collectively suggest a
correlation between HP1 binding to methylated H3-K9
and its ability to repress transcription. Consistent with
the finding that the localization of Swi6p to heterochro-
matin requires the HMT activity of Clr4 in S. pombe
(Bannister et al. 2001; Nakayama et al. 2001), HP1 local-
ization was found to be dispersed in Suv39h1-null
PMEFs. Importantly, the dispersed localization of HP1 in
the mutant cells could be rescued to heterochromatin
foci by retroviral expression of the SUV39H1 (Lachner et
al. 2001). Thus, methylation of H3-K9 can serve as a
recognition site for the chromodomain of HP1/Swi6p. It
is important, however, to point out that although the
chromodomain of HP1 has affinity for methylated his-
tone H3-K9, it appears that alternative pathways for HP1
recruitment also exist (Fig. 7, and see below).
The molecular events leading to the formation of het-
erochromatin at the centromere and mating-type loci
have been recently addressed (Nakayama et al. 2001).
Chromatin immunoprecipitation experiments demon-
strated that Clr4 preferentially methylates H3-K9 at het-
erochromatin-associated regions in S. pombe. In addition
to the SET domain, the chromodomain of Clr4 was
found to be required for H3-K9 methylation in vivo. Im-
portantly, mutations in clr3, a gene encoding a H3-spe-
cific histone deacetylase, impaired H3-K9 methylation
and heterochromatin localization of Swi6 (Nakayama et
al. 2001). These important observations suggest that his-
tone deacetylation functions upstream of H3-K9 meth-
ylation and Swi6 localization. Because mutations in Clr3
affected specifically histone H3-K14 acetylation levels,
deacetylation of K14 seems to be a pre-requirement for
H3-K9 methylation. Because acetylation on H3-K9 pre-
vents this site from being methylated (Rea et al. 2000),
deacetylation of H3-K9 is also a prerequisite for methyl-
ation. As discussed above, Clr4 is required for the local-
ization of Swi6 to heterochromatin (Ekwall et al. 1996).
However, Swi6 mutations do not cause any detectable
changes in methylation of H3-K9 (Nakayama et al.
2001). Therefore, Swi6 likely functions downstream of
Clr4. On the basis of the above observations, a temporal
event for heterochromatin formation can be inferred (Fig.
7A). After removal of the acetyl groups from K9 and K14
of histone H3 by histone deacetylases, Suv39h1/Clr4
methylates H3-K9. Methylated H3-K9 serves as a bind-
ing site for the recruitment of HP1/Swi6. HP1/Swi6,
through the shadow chromodomain located at its car-
boxyl terminus, can oligomerize to form heterochroma-
tin (Brasher et al. 2000). One piece of evidence that sup-
ports this model is the finding that Swi6 remains asso-
Figure 6. Models depicting the relationship between DNA
methylation, histone deacetylation, and histone methylation.
(A) Methyl-CpG-binding proteins recruit HDAC complex to
deacetylate histone so that the histone tails will be suitable for
subsequent methylation by HMTs. (B) In chromatin domains
where histones are hypoacetylated, the MBD domain-contain-
ing HMTs may bind directly and methylate the histones. (C)
Methylated histone tails may recruit DNMTs to methylate
DNA for long-term gene silencing.
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ciated with the mating-type locus mat2/3 throughout
the cell cycle (Nakayama et al. 2000). This finding sug-
gests that Swi6 might play an important role in the in-
heritance of the silenced state of the heterochromatin.
Importantly, it is currently unknown whether oligomer-
ization of Hp1/Swi6 requires H3-K9 methylation at each
nucleosome.
The studies described above demonstrated an impor-
tant role for H3-K9 methylation in the recruitment of
Swi6/HP1 and heterochromatin silencing. However, evi-
dence supporting alternative pathways for HP1 recruit-
ment does exist. For example, it was recently demon-
strated that HP1 interacts with the globular histone fold
domain of H3 as well as with the linker histone H1
through the chromodomain and hinge region, respec-
tively (A.L. Nielsen et al. 2001). Because HP1 can oligo-
merize through its shadow chromodomain (Brasher et al.
2000), it is possible that the chromodomains of the HP1
oligomers can also interact with the histone fold.
In addition to heterochromatin silencing, recent stud-
ies indicate that HP1 is involved in silencing of specific
genes in euchromatin (Fig. 7B). It was found that Rb,
through its pocket domain, interacts with HP1 and
SUV39H1 in vivo to regulate the expression of the cyclin
E gene (S.J. Nielsen et al. 2001). Targeting of Rb to the
cyclin E gene occurs through the transcription factor
E2F. The expression level of cyclin E is elevated in
SUV39H1-disrupted fibroblasts. Chromatin immunopre-
cipitation experiments indicate that Rb is required for
methylation of H3-K9 as well as for HP1 recruitment to
the cyclin E promoter (S.J. Nielsen et al. 2001). In con-
trast to the spreading of H3-K9 methylation and HP1
binding in heterochromatin, Rb-mediated SUV39H1/
HP1 recruitment and H3-K9 methylation occurred
within one nucleosome surrounding the cyclin E pro-
moter (S.J. Nielsen et al. 2001). Recruitment of histone
deacetylases by Rb was shown previously to be part of
the mechanism by which Rb mediates transcription re-
pression (Brehm et al. 1998; Luo et al. 1998; Magnaghi-
Jaulin et al. 1998). The involvement of HMT activity in
Rb-mediated transcription repression suggests again that
HDACs and HMTs may work in concert in the silencing
of euchromatic genes. Moreover, recent studies with
E2F-6, a member of the E2F-family of transcription fac-
tors that functions in G0 in an Rb-independent manner,
demonstrate that E2F-6 also exists in a protein complex
Figure 7. Stepwise models for HP1 in
heterochromatin and euchromatin gene si-
lencing. (A) Heterochromatin formation.
Acetyl groups are removed from lysine
residues by HDACs before Suv39h1/Clr4
can add a methyl group to Lys 9. The chro-
modomain of HP1 recognizes and binds to
methyl-K9 to initiate heterochromatin
formation. The heterochromatin is propa-
gated by self-association of HP1 through
its shadow chromodomain. In addition to
recognizing methyl-K9, HP1 can also bind
to the globular domain of H3. (B) Silencing
of euchromatic genes by HP1. Transcrip-
tion factors, such as E2F, recruit Suv39h1/
HP1 complex through the tumor suppres-
sor Rb to a specific gene promoter. After
methylation of H3-K9 by Suv39h1, HP1
binds and represses transcription.
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with HP1 and an HMT (D. Livingston and Y. Nakatani,
pers. comm.). Whether this complex also contains an
HDAC remains to be determined. However, the above
studies collectively illustrate alternative pathways by
which HP1 can be recruited to different genes to silence
their expression. More importantly, the studies with Rb
regulating the expression of cyclin E though nucleosome
methylation strongly suggest that this modification
must be removed at every cell cycle event. Whether this
removal is mediated by histone demethylation, the pro-
cessing of the histone polypeptide, and/or histone degra-
dation is an important open question (see below).
Can lysine methylation be a mark for transcription ac-
tivation? Although the studies described above indi-
cate that H3-K9 methylation functions as a repressive
mark, not all lysine methylation appears to be a signal
for repression of transcription. It appears that a particular
modification, such as methylation at H3-K9, might have
a different readout depending on its chromosomal loca-
tion and combination of modifications and the enzyme
(or protein complex) involved in the particular modifica-
tion. A recent report has suggested that the histone acet-
yltransferase p300/CBP interacts with an H3 histone
methyltransferase with specificity for H3-K9 (Vandel
and Trouche 2001), suggesting that H3-K9 methylation
could potentially be involved in transcriptional activa-
tion as well. Previous studies have indicated that a SET
domain-containing protein ASH1 (absent, small, and
homeotic discs) is able to interact with CBP (Bantignies
et al. 2000) suggesting that the p300/CBP-associated his-
tone methyltransferase is likely to be the mammalian
homolog of Drosophila ASH1. ASH1 was recently found
to be capable of methylating multiple lysine residues,
including histone H3-K4 and H3-K9 and histone H4-K20.
Importantly, a single amino acid substitution in the SET
domain crippled the HMT enzymatic activity as well as
ASH1-dependent transcriptional activation (Frank Sauer,
pers. comm.). Therefore, at least four different enzymes
Suv39h1, Suv39h2, G9a (O’Carroll et al. 2000; Rea et al.
2000; Tachibana et al. 2001) and ASH1 have been shown
to methylate H3-K9. Of these four enzymes, only
Suv39h1 and Suv39H2 are specific for H3-K9, the other
two enzymes, G9a and ASH1 apparently can methylate
H3-K9 in combination with other residues. Therefore, it
is possible that methylation at H3-K9 alone results in
transcription repression, whereas methylation at H3-K9
together with methylation at H3-K27 (by G9a, see above)
or methylation at these two residues in combination
with methylation at H4-K20 might result in transcrip-
tion activation. In support of the hypothesis that meth-
ylation at H3-K4 can result in transcription activation,
H3-K4 was found to be a preferred site of methylation in
the transcriptionally active macronuclei of Tetrahy-
mena, and importantly, methylation at H3-K4 correlates
with acetylation (Strahl et al. 1999). Moreover, recent
studies have found that the yeast Set-1 protein, which
apparently targets H3-K4, exists in a complex with tran-
scriptional activators (T. Kouzarides, pers. comm.).
Therefore, it is likely that methylation at H3-K4 inde-
pendently, or in combination with methylation at H3-
K9, results in transcriptional activation. The mecha-
nism(s) by which methylation at H3-K4 results in tran-
scriptional activation is unknown, but it is possible that
methylation at these residues can mark a gene for the
recruitment of complexes involved in activation and/or
can displace complexes involved in transcriptional re-
pression, such as histone deacetylases.
A recent study by Grewal and colleagues demonstrates
that euchromatic and heterochromatic chromosomal do-
mains have distinctive site-specific H3 methylation pat-
terns (Noma et al. 2001). Chromatin immunoprecipita-
tion (ChIP) experiments with antibodies specific to H3-
K9 and H3-K4 and expanding the fission yeast mating-
type locus have revealed that H3-K9 methylation is
strictly localized to a 20-kb silent heterochromatic re-
gion, whereas H3-K4 methylation is specific to the sur-
rounding euchromatic regions (Fig. 8). Importantly, two
inverted repeats that flank the silent interval serve as
boundary elements for heterochromatin and euchroma-
tin as deletions of these boundary elements lead to
spreading of H3-K9 methylation into the neighboring se-
Figure 8. Differential sites of histone H3 methylation mark euchromatic and heterochromatic regions at the fission yeast mat
locus. (Top) Physical map of the mating-type region. IR-L and IR-R, shown as black arrows, denote inverted repeats residing on both
sides of the mat2/3 interval and within is cenH, with homology to centromeric repeats. (Boxes) Open reading frames, including
the essential let1+ gene; (arrows) direction of transcription. The graph represents a summary of ChIP experiments throughout the
mat locus with H3-K4 (blue) and H3-K9 (red) methyl-specific antibodies (for details, see Noma et al. 2001). Courtesy of Dr. Shiv
Grewal.
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quences (Noma et al. 2001). These studies collectively
support the idea that site-specific methylation can serve
as chromatin domain markers.
Interplay between different histone tail modifications
As discussed above, histone tails are rich in residues that
can be covalently modified (Fig. 1). Increasing evidence
indicates that the different modifications can affect each
other (Fig. 9). For example, several transcription-related
HATs including GCN5, PCAF, and p300, prefer S10
phosphorylated H3 as a substrate (Cheung et al. 2000; Lo
et al. 2000).
Studies in Tetrahymena demonstrated that phos-
phorylation of H3-S10 is required for proper chromo-
some condensation and segregation (Wei et al. 1999). The
enzymes responsible for adding and removing the phos-
phate group from H3-S10 were identified as the Ipl1p/
aurora-2 kinase and Glc7p/PP1 phosphatase, respec-
tively (Hsu et al. 2000). Recent studies have demon-
strated, however, that phosphorylation of H3-S10 also
occurs during interphase, and importantly it correlates
with transcriptional activation. The RSK-2 kinase was
found to be activated in response to different effectors
resulting in the phosphorylation of different transcrip-
tion factors as well as phosphorylation of histone H3-S10
(Sassone-Corsi et al. 1999). Moreover, recent studies in
yeast have revealed that the Snf1 kinase phosphorylates
histone H3-S10 and that this phosphorylation is required
for transcriptional activation of certain yeast genes
(Lo et al. 2001). These findings collectively demon-
strate that more than one kinase is involved in H3-S10
phosphorylation and that the phosphorylation status of
H3-S10 plays an important role in transcriptional regu-
lation.
H3-S10 phosphorylation facilitates GCN5-mediated
acetylation of H3-K14 (Cheung et al. 2000; Lo et al.
2000). By use of antibodies that specifically recognize
phosphorylated H3-S10 or acetylated H3-K14, as well as
a specific antibody recognizing both modifications, it
was uncovered that following EGF treatment, the accu-
mulation of singly phosphorylated H3 preceded H3-K14
acetylation (Cheung et al. 2000). A simple explanation
for this observation is that phosphorylation is followed
by acetylation to generate the dimodified H3 (Fig. 9).
These sequential events were also observed in yeast. It
was found that phosphorylation of H3-S10 promotes sub-
sequent acetylation of H3-K14 by GCN5. Importantly,
acetylation of H3-K14 had no effect on phosphorylation
of histone H3-S10 (Lo et al. 2000). Moreover, a mutation
in the GCN5 HAT domain (R164A) selectively crippled
H3-S10 phosphorylation-enhanced acetylation whereas
the mutation had no significant affect on the acetylation
of nonphosphorylated substrate. Importantly, this muta-
tion also affected the activity of a subset of GCN5-regu-
lated promoters in vivo (Lo et al. 2000). These results
suggest that the enhanced acetylation of H3-K14 medi-
ated by phosphorylation of H3-S10 plays an important
role in transcription of a subset of GCN5-regulated
genes.
In addition to the interplay observed between H3-S10
phosphorylation and H3-K14 acetylation, phosphoryla-
tion on histone H3-S10 also plays an important role in
regulating lysine methylation. It was recently reported
that methylation of histone H3-K9 by SUV39H1 was
greatly inhibited when an H3-tail peptide phosphory-
lated at S10 was used as a substrate (Rea et al. 2000).
Similarly, methylation on H3-K9 inhibits subsequent
phosphorylation of H3-S10. As expected, acetylation and
methylation of histone H3-K9 are mutually exclusive
(Fig. 9). This observation is not surprising as methyla-
tion of H3-K9 correlates with gene silencing, whereas
acetylation of histone H3-K9 correlates with transcrip-
tional activation. The interplay observed between phos-
phorylation and acetylation is consistent with the find-
ings that activation of different signal transduction path-
ways, resulting in the transcription of specific genes
Figure 9. Interplay between different post-translational modifications occurring on histone H3 and H4 amino-terminal tails. Resi-
dues that are known to be acetylated (Ac), methylated (Me), and phosphorylated (P) are indicated. Positive and negative affects are
indicated.
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correlates with phosphorylation of histone H3-S10.
Phosphorylation on H3-S10, in turn, inhibits methyl-
ation of histone H3-K9, and promotes acetylation of his-
tone H3-K14, a modification present on transcriptionally
active genes.
Similar to histone H3, multiple modifications also ex-
ist on the histone H4 tail. In addition to the well-char-
acterized lysine acetylation (Lys 5, Lys 8, Lys 12, and Lys
16), methylation at Lys 20 and phosphorylation at Ser 1
have also been documented (Strahl and Allis 2000; Fig.
1). Adding to this complexity is the recent discovery that
H4-R3 can also be methylated by PRMT1 (see above and
Wang et al. 2001; Strahl et al. 2001). Significantly, meth-
ylation on H4-R3 facilitates acetylation by p300 on his-
tone H4-K8 and H4-K12 (Fig. 9). Consistent with a role in
facilitating p300-mediated lysine acetylation, the meth-
yltransferase activity of PRMT1 was found to stimulate
transcription (Wang et al. 2001). The interplay between
H4-R3 methylation and lysine acetylation is not unidi-
rectional. Lysine acetylation can also affect subsequent
H4-R3 methylation (Fig. 9). It was found that acetylation
on any of the four lysines on the histone H4 amino-
terminal tail inhibits subsequent methylation on H4-R3
by PRMT1 (Wang et al. 2001). On the basis of the rela-
tionship between H4-R3 methylation and lysine acety-
lation, it is likely that H4-R3 methylation precedes ly-
sine acetylation.
The histone code hypothesis predicts that different
functional domains present in different polypeptides rec-
ognize different histone modifications. Thus far, acetyl-
lysines and methyl-lysine 9 have been found to be
recognized by bromodomain- (Dhalluin et al. 1999; Ja-
cobson et al. 2000) and chromodomain-containing
polypeptides (Bannister et al. 2001; Lachner et al. 2001;
Nakayama et al. 2001), respectively. This recognition ap-
pears to be highly specific, as not all chromodomain-
containing proteins bind to methylated H3-K9. It is
likely that the residues within and surrounding the chro-
modomain determine specificity. Understanding the
function of the different modifications occurring on
the histone tails will be greatly facilitated by eluci-
dating the domains responsible for recognition of
modifications occurring at other residues (H3-K4-
methyl, H3-S10-phospho, H4-R3-methyl, and H4-K20-
methyl). Because methylation on histone H4-R3
makes H4 a better substrate for p300-mediated acetyla-
tion (Wang et al. 2001), methylated H4-R3 might be a
recognition signal for the bromodomain of p300. Three
arginines of the histone H3 amino-terminal tails
(Arg 2, Arg 17, and Arg 26) were recently shown to
be methylated by CARM1 in vitro (Schurter et al.
2001). Therefore, 11 of 28 amino acids of the histone
H3-tail are subject to one or two types of post-transla-
tional modification (Fig. 1). Given the interplay between
different modifications, which theoretically can occur
within or between different histone tails, the combina-
tions of modifications with a mononucleosome is
enormous. Moreover, some of these modifications are
likely to be regulated by regions within chromosomes.
Therefore, the interplay between the different modifica-
tions directly contributes to the diversity of the histone
code.
Future directions
Histone methylation was discovered three decades ago.
Its functional significance has just begun to be addressed.
The discovery of the first HAT was instrumental in dis-
secting the function of histone acetylation. Similarly,
the discovery of CARM1, SUV39H1, and PRMT1 as
HMTs will greatly help our understanding of the func-
tion of histone methylation. We anticipate a flurry of
research isolating and characterizing HMTs as well as
defining genes or gene complexes that are regulated by
specific HMTs. The interplay between HMTs, histone
acetylation and histone phosphorylation in regulating
specific set of genes is forthcoming.
As discussed in this review, two families of HMTs
with distinct substrate (arginine and lysine) and site
specificity have been discovered. The known functions
of these two family of proteins predict that histone
methylation is likely to play important roles in multiple
biological processes including transcription, signal trans-
duction, development, and cellular proliferation and dif-
ferentiation. To understand how histone methylation
participates in the above biological processes, progress in
several areas of histone methylation study are needed.
First, the sites of histone methylation need to be further
characterized in vivo. Although some of the major sites
for H3 and H4 are known, the methylation sites for H2A
and H2B are poorly characterized. With the use of more
sensitive detection methods, we anticipate that novel
methylation sites will be discovered. Second, the func-
tional significance for each methylated residue needs to
be determined. The generation of antibodies specifically
recognizing modified residues will provide an important
tool in this regard. Third, the use of biochemical purifi-
cation and sequence similarity approaches will likely
lead to the discovery of novel HMTs, some of which are
likely to contain unique catalytic domains other than
the SET domain or the conserved arginine methyltrans-
ferase motifs. An important issue is the identification of
HMTs that can use nucleosomal histones as substrates.
It is also important to knowwhether nucleosome remod-
eling is required for HMTs to methylate nucleosomal
histones.
Unlike the dynamic process of histone acetylation,
histone methylation is believed to be relatively static
(Shepherd et al. 1971; Byvoet et al. 1972). However,
changes in histone methylation levels during the cell
cycle or in response to heat shock have been reported
(Camato and Tanguay 1982; Annunziato et al. 1995).
Whether enzymes responsible for the removal of the
methyl group from histones exist still remains to be de-
termined. If histone demethylases (HDMs) do not exist,
cells would have had to develop systems to deal with the
consequence of this modification. For example the meth-
ylated histones could be more susceptible to degradation
so that histone methylation can be regulated. Enzymes
with demethylase activity have been previously reported
Zhang and Reinberg
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(J. Lee et al. 1996). However, enzymes capable of actively
demethylating histone polypeptides remain to be discov-
ered. Characterization of the HMTs and HDMs will have
great impact on the study of many biological processes in
which histones play a role. It is likely that histone meth-
ylation, like DNA methylation, may mark genes, or
chromosomal regions. Whether these marked regions
can become transcriptionally active through active de-
methylation or processes requiring repair or coupled to
protein degradation remains an extremely important
question. Of interest are earlier observations suggesting
that the tails of histone H3 (Allis et al. 1980) and H4 (Lin
et al. 1991) are subject to proteolytic processing and that
a ubiquitin-specific protease suppresses variegation in
Drosophila (Henchoz et al. 1996).
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